Last month, against the backdrop of rising marketplace premiums and declining enrollment, the Trump administration finalized extensive regulations governing HealthCare.gov and the state-based marketplaces. Some of the new rule trods familiar ground: it establishes restrictions on the enrollment process that the administration has previously sought to impose but that have been set aside by the courts. Other parts, however, enter uncharted territory. The rule contains several novel deregulatory policies that give insurers significant flexibility to develop and sell new marketplace products as early as next year. In a blog post for the Commonwealth Fund, CHIR’s Justin Giovannelli looks at what the rulemaking can tell us about the administration’s priorities during this period of uncertainty.
You can read the full blog post here.
